SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Restructurings
An SI Board Since September 2002
Posts SubjectMarks Bans
270 25 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
195Karo Bio To Focus Its Operations Thursday October 11, 3:11 am ET Karo Bio updatenigel bates-10/11/2007
194Idenix (IDIX) 33% siliconinvestor.com Cheers, Tucktuck-9/28/2007
193Palatin (PTN) - 30% CRANBURY, N.J., Sept. 26 /PRNewswire-FirstCall/ -- Palatin Icebrg-9/26/2007
192Nanogen (NGEN) %: >>Nanogen to reduce workforce by 4 pct Fri Sep 21, 2007tuck-9/25/2007
191Sunesis (SNSS) 25%: >>Sunesis Pharmaceuticals Announces Reorganization totuck-8/28/2007
190AMGEN, 12-14%.scaram(o)uche-8/15/2007
189Pharmos Corp. (Nasdaq: PARS) today published its financial report for the secondidos-8/9/2007
188ANDS to lay off 33%. In connection with the decision to discontinue the developkeokalani'nui-8/2/2007
187Nuvelo to Cut 30 Percent of Work Force Wednesday August 1, 4:59 pm ET Nuvelo to sim1-8/1/2007
186ASPV- Aspreva Restructuring Will Cut 33 Jobs, or 25 Percent of Workers and replaidos-7/26/2007
185POTP exceeded announced plans of 60% with an actual 74% reduction. biz.yahoo.copgo-neil-7/12/2007
184ENCY 70%, including CEO & COO, and all of U.S. sales force: Message 2365140tuck-6/25/2007
183POTP cuts 60% of workforce to extend survival by a month or so... They have abopgo-neil-5/31/2007
182AtheroGenics cuts 50 pct jobs to focus on heart drug Fri May 25, 2007 9:32 AM ETidos-5/25/2007
181NKTR - 25 % NEW YORK, May 24 (Reuters) - Nektar Therapeutics Inc. (NKTR.O: QuotIcebrg-5/24/2007
180CVTX sheds about $75Mil expenses to reach profitability sooner. However, at the pgo-neil-5/24/2007
179Hollis-Eden (HEPH) 25% From Briefing.com this morning: >>Hollis-Eden Phatuck-4/27/2007
178>>Avanir Pharmaceuticals Provides Business Update and Announces Restructurtuck-3/29/2007
177Privately Held Tripos Discovery Informatics: Jim Hopkins Chief Executive OfficerMike McFarland-3/26/2007
176ITMN - 50% <b>InterMune Updates Expense Forecasts </b>and DevelopmeIcebrg-3/22/2007
175Tripos 100%. Finally, finality. This last stage, should be a case study. <keokalani'nui-3/15/2007
174TELK -25% Telik Announces Corporate Restructuring Tuesday February 13, 4:30 pm Icebrg-2/13/2007
173LGND -76% incl. the CFO. Drugmaker Ligand Pharmaceuticals Inc. said it will cutIcebrg-1/31/2007
172DOV Pharmaceutical Announces Entry Into Restructuring Support Agreement Thursdaynigel bates-1/25/2007
171Renovis -40%. Renovis Restructures to Focus on Advancing Its Neurological and Ikeokalani'nui-1/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News